(S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)-4-(dimethylamino)but-2-en-1-one

ID: ALA5278505

Max Phase: Preclinical

Molecular Formula: C25H29N7O3

Molecular Weight: 475.55

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C#Cc2nn([C@H]3CCN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1

Standard InChI:  InChI=1S/C25H29N7O3/c1-30(2)10-5-6-22(33)31-11-9-18(15-31)32-25-23(24(26)27-16-28-25)21(29-32)8-7-17-12-19(34-3)14-20(13-17)35-4/h5-6,12-14,16,18H,9-11,15H2,1-4H3,(H2,26,27,28)/b6-5+/t18-/m0/s1

Standard InChI Key:  KWRNFDMMNZXXJC-QWNKOJSDSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -0.5705   -0.8441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0507    0.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3367   -0.2136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6185    0.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6185    1.0306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3367    1.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0507    1.0306    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3409    0.6130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8252   -0.0591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8252    1.2851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5705    2.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3158    2.8635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0570    3.6526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6122    4.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575    5.0597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4524    5.2309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0076    4.6130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7530    3.8239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8177    4.7884    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4064    4.1996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9128    5.6735    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7229    5.5023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3367    2.2748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0521   -1.5142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5673   -2.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2178   -1.9269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2178   -1.1020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9286   -2.3492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9183   -3.1758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6496   -1.9447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6291   -3.5980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6188   -4.4246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3296   -4.8469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3193   -5.6735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0507   -4.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  8  9  1  0
  4  9  1  0
  1  9  1  6
  8 10  2  0
  5 10  1  0
 10 11  1  0
 11 12  3  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 17 19  1  0
 19 20  1  0
 15 21  1  0
 21 22  1  0
  6 23  1  0
  1 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27  1  1  0
 26 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5278505

    ---

Associated Targets(Human)

FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU-16 (476 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU1 (253 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.55Molecular Weight (Monoisotopic): 475.2332AlogP: 1.72#Rotatable Bonds: 6
Polar Surface Area: 111.63Molecular Species: BASEHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.81CX LogP: 1.59CX LogD: 0.17
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.42Np Likeness Score: -0.83

References

1. Ito S, Otsuki S, Ohsawa H, Hirano A, Kazuno H, Yamashita S, Egami K, Shibata Y, Yamamiya I, Yamashita F, Kodama Y, Funabashi K, Kazuno H, Komori T, Suzuki S, Sootome H, Hirai H, Sagara T..  (2023)  Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use.,  14  (4): [PMID:37077386] [10.1021/acsmedchemlett.3c00006]

Source